What’s Fueling Oncology Institute Inc (TOI) Stock’s -77.57% Loss Below Its 200-Day SMA?
Jefferies has recently resumed Oncology Institute Inc (TOI) stock to Buy rating, as announced on February 26, 2024, according to Finviz. Earlier, on September 14, 2022, Guggenheim had initiated the stock to Buy, setting a price target of $7. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and […]
Airship AI Holdings Inc (AISP) Posted 133.10% Profit Margin Last Year—Can It Hold Up?
The Benchmark Company has recently initiated Airship AI Holdings Inc (AISP) stock to Buy rating, as announced on November 13, 2024, according to Finviz. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment. Airship AI Holdings Inc (AISP) Stock Trading Recap On Friday, Airship AI Holdings […]
Tivic Health Systems Inc (TIVC) Reported a -601.17% Operating Margin Last Year—What’s the Real Story?
Tivic Health Systems Inc (TIVC) Stock Trading Recap On Friday, Tivic Health Systems Inc (TIVC) stock saw a decline, ending the day at $0.29 which represents a decrease of $-0.08 or -21.62% from the prior close of $0.37. The stock opened at $0.3 and touched a low of $0.25 during the day, reaching a high […]
What’s Driving Bitcoin Depot Inc (BTM) Stock’s 34.23% Surge Over the Past Month?
Bitcoin Depot Inc (BTM) Stock Trading Recap On Friday, Bitcoin Depot Inc (BTM) stock saw a decline, ending the day at $2 which represents a decrease of $-0.43 or -17.70% from the prior close of $2.43. The stock opened at $2.48 and touched a low of $1.92 during the day, reaching a high of $2.48. […]
Why Did Rekor Systems Inc (REKR) Stock Tumble -17.59% to $0.89?
William Blair has recently initiated Rekor Systems Inc (REKR) stock to Outperform rating, as announced on March 4, 2024, according to Finviz. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment. Rekor Systems Inc (REKR) Stock Trading Recap On Friday, Rekor Systems Inc (REKR) stock saw […]
Analysts Predict a $16 Target for Emergent Biosolutions Inc (EBS) Stock—What Could Drive It There?
Rodman & Renshaw has recently initiated Emergent Biosolutions Inc (EBS) stock to Buy rating, as announced on August 22, 2024, according to Finviz. Earlier, on March 7, 2024, The Benchmark Company had raised the stock from a Hold to Buy, setting a price target of $5. JP Morgan also resumed Underweight rating. Additionally, The Benchmark […]
What’s Behind the -15.59% Drop in Avidity Biosciences Inc (RNA) Stock? Find Out Now!
Goldman has recently initiated Avidity Biosciences Inc (RNA) stock to Buy rating, as announced on September 24, 2024, according to Finviz. Earlier, on August 28, 2024, Barclays had initiated the stock to Overweight, setting a price target of $63. BofA Securities also initiated Buy rating with a price target of $40. Additionally, Cantor Fitzgerald initiated […]
Goldman Just Initiated Arrowhead Pharmaceuticals Inc (ARWR) Stock—What Does This Mean for Investors?
Goldman has recently initiated Arrowhead Pharmaceuticals Inc (ARWR) stock to Neutral rating, as announced on June 5, 2024, according to Finviz. Earlier, on December 4, 2023, BofA Securities had initiated the stock to Buy, setting a price target of $29. Citigroup also initiated Neutral rating with a price target of $33. Additionally, TD Cowen initiated […]
How Does Ginkgo Bioworks Holdings Inc (DNA) Stack Up Against Its Industry Peers?
BTIG Research has recently reduced Ginkgo Bioworks Holdings Inc (DNA) stock to Sell rating, as announced on May 15, 2024, according to Finviz. Earlier, on May 10, 2024, William Blair had reduced the stock from a Mkt Perform to Underperform. Raymond James also reduced Mkt Perform rating with a price target of $2.50. Additionally, BTIG […]
Origin Materials Inc (ORGN) Stock: More Strategic Than Meets the Eye
BofA Securities has recently raised Origin Materials Inc (ORGN) stock to Buy rating, as announced on August 16, 2024, according to Finviz. Earlier, on August 11, 2023, Craig Hallum had reduced the stock from a Buy to Hold, setting a price target of $2. Credit Suisse also initiated Outperform rating with a price target of […]